To The Moon

It has been stable for years

Holding on when you bought in at a good price is a reasonable decision. However, if one entered due to the hype, it might be wise to divest and enter again after the rate cuts take effect and everything settles down. There had to be expectations that the interest rates would have to fall and have realistic expectations (even though the belief in SG banks as a stable and safe option is the prevalent sentiment). As above, wait for the rate cuts to take effect, the lag to clear up then enter at a better price since SG banks are reasonably safe investments.

Find out more here:Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now!

Find out more here:Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now!

Find out more here:Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now!

Regional bank stocks (including DBS) are consolidating after a sharp rally. Traders are cautious ahead of earnings — waiting for clarity on net interest margins and dividend outlook. No negative news specific to DBS; just normal rotation and short-term profit-taking.

Regional bank stocks (including DBS) are consolidating after a sharp rally. Traders are cautious ahead of earnings — waiting for clarity on net interest margins and dividend outlook. No negative news specific to DBS; just normal rotation and short-term profit-taking.

If big guys zlow, go for ifast

With rate cuts on the horizon, the market is shifting from “higher for longer” to “soft landing” optimism — but that doesn’t mean investors should abandon discipline. Dividend plays remain attractive as yields stay higher than risk-free rates for now, offering steady income and downside cushioning. However, as rates fall, capital tends to rotate toward growth and cyclicals, which benefit from cheaper borrowing and renewed demand. If your portfolio already leans defensive, gradually adding quality growth names — especially in tech, industrials, or consumer recovery themes — could position you ahead of the cycle. For more risk-averse investors, holding dividend stalwarts with strong cash flow (banks, telcos, REITs) still makes sense through the transition. Personally, I’d accumulate selecti

$DBS(D05.SI)$ $UOB(U11.SI)$ $OCBC Bank(O39.SI)$ Singapore’s three banking giants — DBS Group Holdings (SGX: D05), Oversea-Chinese Banking Corporation (OCBC, SGX: O39), and United Overseas Bank (UOB, SGX: U11) — have all slipped in recent sessions, marking a cautious turn for the sector as investors brace for a potential Federal Reserve rate cut cycle. The sector’s stellar run through 2023 and early 2024, fueled by elevated net interest margins (NIMs) and record earnings, now faces a period of recalibration. As global monetary policy shifts from tightening to easing, investors are reassessing their strategies: Are Singapore’s banks still worth holding in the

Definitely buy more strong bank stocks and hold long term for dividend income.

Find out more here:Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now!

For sure, I keep holding for income. $DBS Group Holdings(D05.SI)$ never disappointed me.

Genprex (GNPX) disclosed that it received notices of allowance for patents from both the U.S. and European Patent Offices for its Reqorsa® Gene Therapy in combination with PD-L1 and PD-1 antibodies, with patents expiring in 2037. This development supports Genprex’s Acclaim-3 clinical trial for small cell lung cancer, which has received FDA Fast Track and Orphan Drug Designations, potentially enhancing the company’s market position and stakeholder confidence. More about Genprex Genprex, Inc. operates in the biotechnology industry, focusing on developing gene therapies for cancer and diabetes. The company is known for its lead drug candidate, Reqorsa® Gene Therapy, which targets cancer treatment through innovative combinations with immunotherapy drugs.

Top 5 Future Blue-Chip Stocks in Singapore for 2025 🚀 - High Potential Picks! https://youtu.be/cvEqftS15fE$Olam Group(VC2.SI)$  $Suntec Reit(T82U.SI)$  $NetLink NBN Tr(CJLU.SI)$  

Top 5 Future Blue-Chip Stocks in Singapore for 2025 🚀 - High Potential Picks! https://youtu.be/cvEqftS15fE $Olam Group(VC2.SI)$  $NetLink NBN Tr(CJLU.SI)$  $Suntec Reit(T82U.SI)$  

🌟🌟🌟With rate cuts on the horizon Singapore REITs will be great buys as they are poised for a meaningful rebound. Rate cuts will reduce borrowing costs for SReits, boosting distributable income and improve dividend sustainability. With Singapore banks facing margin pressure from rate cuts, it is a good time to rotate into SReits especially those with resilient portfolio like $CapLand IntCom T(C38U.SI)$ and $Mapletree Ind Tr(ME8U.SI)$. It is time for SReits to shine again. @Tiger_SG @TigerStars @Tiger_comments

🌟🌟🌟With interest rate cuts on the horizon, Singapore bank stocks like DBS, OCBC and UOB offer a rare blend of dividend income and capital growth. All 3 Singapore banks have a phenomenal track record of capital growth - and at the same time maintaining consistent dividends. I am a long term investor of all 3 banks and they have rewarded  me with great dividends and fantastic capital growth.  Despite the recent pullbacks I am not selling as it is hard to find such great Singapore stocks to buy and hold long term. @Tiger_SG @Tiger_comments @TigerStars @CaptainTiger

The strategy for banks is to maximise growth and seek to invest in banks gaining market share $Goldman Sachs(GS)$ 1. Prefer holding for growth with average dividend payment 2. Growth and cyclical investments depend on state of the economy 3. There will always be opportunities to increase positions in times of market stress The key to investing in banks is to see growth in growing banks

long term 5 to over 10 years

$DBS(D05.SI)$ $UOB(U11.SI)$ $OCBC Bank(O39.SI)$ Singapore’s three banking giants — DBS Group Holdings (SGX: D05), Oversea-Chinese Banking Corporation (OCBC, SGX: O39), and United Overseas Bank (UOB, SGX: U11) — have all slipped in recent sessions, marking a cautious turn for the sector as investors brace for a potential Federal Reserve rate cut cycle. The sector’s stellar run through 2023 and early 2024, fueled by elevated net interest margins (NIMs) and record earnings, now faces a period of recalibration. As global monetary policy shifts from tightening to easing, investors are reassessing their strategies: Are Singapore’s banks still worth holding in the

Singapore’s three banking giants — $DBS(D05.SI)$ , $OCBC Bank(O39.SI)$ , and $UOB(U11.SI)$ — have all retreated recently, as investors brace for an expected Fed rate cut cycle. The question now is: where’s the focus when growth slows but dividends stay strong?DBS: The Dividend AnchorDBS just delivered another solid quarter — total revenue up 6% YoY to S$5.9B and net profit at S$2.9B, slightly lower due to global minimum tax adjustments.Still, the bank rewarded shareholders with a S$0.75 per-share dividend, up nearly 39% YoY, including a special S$0.15 capital return.At current levels (~S$54.8), that’s a ~5.5% yield — one of the highest in the region.Why Div

I maintain two strategies — one focused on growth stocks and another on dividend plays like Singapore’s major banks. With rate cuts approaching, I still value DBS, OCBC, and UOB for their strong balance sheets and reliable payouts. DBS, in particular, remains my core dividend holding thanks to its consistent earnings and attractive yield. At the same time, I keep a separate growth portfolio targeting sectors like technology and AI, where structural trends continue to drive earnings expansion. This helps balance the slower but steadier returns from dividend stocks, giving me exposure to both stability and long-term upside. Rather than rotating fully into one side, I stay flexible — adding selectively during market pullbacks. If bank valuations dip further, I’ll top up for yield; and if gro

With rate cuts on the horizon, the market is shifting from “higher for longer” to “soft landing” optimism — but that doesn’t mean investors should abandon discipline. Dividend plays remain attractive as yields stay higher than risk-free rates for now, offering steady income and downside cushioning. However, as rates fall, capital tends to rotate toward growth and cyclicals, which benefit from cheaper borrowing and renewed demand. If your portfolio already leans defensive, gradually adding quality growth names — especially in tech, industrials, or consumer recovery themes — could position you ahead of the cycle. For more risk-averse investors, holding dividend stalwarts with strong cash flow (banks, telcos, REITs) still makes sense through the transition. Personally, I’d accumulate selecti

Genprex (GNPX) disclosed that it received notices of allowance for patents from both the U.S. and European Patent Offices for its Reqorsa® Gene Therapy in combination with PD-L1 and PD-1 antibodies, with patents expiring in 2037. This development supports Genprex’s Acclaim-3 clinical trial for small cell lung cancer, which has received FDA Fast Track and Orphan Drug Designations, potentially enhancing the company’s market position and stakeholder confidence. More about Genprex Genprex, Inc. operates in the biotechnology industry, focusing on developing gene therapies for cancer and diabetes. The company is known for its lead drug candidate, Reqorsa® Gene Therapy, which targets cancer treatment through innovative combinations with immunotherapy drugs.

Holding on when you bought in at a good price is a reasonable decision. However, if one entered due to the hype, it might be wise to divest and enter again after the rate cuts take effect and everything settles down. There had to be expectations that the interest rates would have to fall and have realistic expectations (even though the belief in SG banks as a stable and safe option is the prevalent sentiment). As above, wait for the rate cuts to take effect, the lag to clear up then enter at a better price since SG banks are reasonably safe investments.

🌟🌟🌟With interest rate cuts on the horizon, Singapore bank stocks like DBS, OCBC and UOB offer a rare blend of dividend income and capital growth. All 3 Singapore banks have a phenomenal track record of capital growth - and at the same time maintaining consistent dividends. I am a long term investor of all 3 banks and they have rewarded  me with great dividends and fantastic capital growth.  Despite the recent pullbacks I am not selling as it is hard to find such great Singapore stocks to buy and hold long term. @Tiger_SG @Tiger_comments @TigerStars @CaptainTiger

🌟🌟🌟With rate cuts on the horizon Singapore REITs will be great buys as they are poised for a meaningful rebound. Rate cuts will reduce borrowing costs for SReits, boosting distributable income and improve dividend sustainability. With Singapore banks facing margin pressure from rate cuts, it is a good time to rotate into SReits especially those with resilient portfolio like $CapLand IntCom T(C38U.SI)$ and $Mapletree Ind Tr(ME8U.SI)$. It is time for SReits to shine again. @Tiger_SG @TigerStars @Tiger_comments

Find out more here:Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now!

The strategy for banks is to maximise growth and seek to invest in banks gaining market share $Goldman Sachs(GS)$ 1. Prefer holding for growth with average dividend payment 2. Growth and cyclical investments depend on state of the economy 3. There will always be opportunities to increase positions in times of market stress The key to investing in banks is to see growth in growing banks

Find out more here:Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now!

Find out more here:Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now!

Regional bank stocks (including DBS) are consolidating after a sharp rally. Traders are cautious ahead of earnings — waiting for clarity on net interest margins and dividend outlook. No negative news specific to DBS; just normal rotation and short-term profit-taking.

Regional bank stocks (including DBS) are consolidating after a sharp rally. Traders are cautious ahead of earnings — waiting for clarity on net interest margins and dividend outlook. No negative news specific to DBS; just normal rotation and short-term profit-taking.

It has been stable for years

Find out more here:Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now!

Find out more here:Cash Boost Lucky Draw Hey friend! Tap to help me out and get a mystery gift for yourself—check it out now!

Top 5 Future Blue-Chip Stocks in Singapore for 2025 🚀 - High Potential Picks! https://youtu.be/cvEqftS15fE$Olam Group(VC2.SI)$  $Suntec Reit(T82U.SI)$  $NetLink NBN Tr(CJLU.SI)$  

Top 5 Future Blue-Chip Stocks in Singapore for 2025 🚀 - High Potential Picks! https://youtu.be/cvEqftS15fE $Olam Group(VC2.SI)$  $NetLink NBN Tr(CJLU.SI)$  $Suntec Reit(T82U.SI)$  

For sure, I keep holding for income. $DBS Group Holdings(D05.SI)$ never disappointed me.